Standard Biotools Inc.

LABCIK 0001162194 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 16, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0208Δ-0.001681% similar+380/-680 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Jun 3, 20265.02 · Departure/Election May 28, 20265.02 · Departure/Election9.01 · Financial Statements and Exhibits May 5, 2026no items parsed Apr 24, 2026no items parsed Feb 24, 2026no items parsed

YoY shift: Lean -

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.16pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Standard Biotools Inc.

Name	Roles	Filings
Casdin Eli	Director10% Owner	34
Casdin Capital, LLC	Director10% Owner	27
Casdin Partners Gp, LLC	Director10% Owner	27
Casdin Partners Master Fund, L.P.	Director10% Owner	27
Casdin Private Growth Equity Fund II Gp, LLC	Director10% Owner	27

Showing 1-5 of 33

Per pagePage 1 of 7Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Standard Biotools Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Casdin Amplify Fund, LP	16	50%	+6.7%	+8.9%	+40.3%	-25.7%
2	Caligan Partners LP	13	0%	-42.1%	-48.3%	-16.7%	-57.0%
3	Johnson David Edward	13	0%	-42.1%	-48.3%	-16.7%	-57.0%
4	Egholm Michael	3	0%	-27.3%	-29.5%	-22.1%	-30.4%
5	Kim Hanjoon Alex	3	0%	-27.3%	-29.5%	-22.1%	-30.4%
6	MacKay Sean	3	0%	-27.3%	-29.5%	-22.1%	-30.4%
7	Casdin Partners Fo1-Msv, LP	12	25%	-10.1%	-25.8%	+47.2%	-38.0%
8	Casdin Private Growth Equity Fund Gp, LLC	49	37%	-4.2%	-7.4%	+40.3%	-38.0%
9	Casdin Private Growth Equity Fund, L.P.	49	37%	-4.2%	-7.4%	+40.3%	-38.0%
10	Casdin Capital, LLC	52	40%	-2.1%	-3.9%	+47.2%	-38.0%

All filings

149 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 8, 2026	Egholm Michael President & CEO · Director	FTax	95,014	$0.908	$86,273
Mar 2, 2026	Carey Thomas D. Director	AGrant	51,282	$1.17	$60,000
Mar 2, 2026	Cox Troy Director	AGrant	57,264	$1.17	$66,999
Mar 2, 2026	Casdin Eli Director · 10% Owner	AGrant	52,991	$1.17	$61,999
Feb 24, 2026	Kim Hanjoon Alex Chief Financial Officer	FTax	12,740	$1.15	$14,651

Showing 6-10 of 149

Per pagePrevPage 2 of 30Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value